Severe Bradycardia and Asystole Following Regadenoson in Pharmacological Myocardial Perfusion Imaging: Cases and Treatment Recommendations

JACC Cardiovasc Imaging. 2019 Jul;12(7 Pt 1):1288-1290. doi: 10.1016/j.jcmg.2019.01.017. Epub 2019 Mar 13.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine A2 Receptor Agonists / adverse effects*
  • Aged
  • Aged, 80 and over
  • Bradycardia / chemically induced*
  • Bradycardia / diagnosis
  • Bradycardia / physiopathology
  • Bradycardia / therapy
  • Female
  • Heart Arrest / chemically induced*
  • Heart Arrest / diagnosis
  • Heart Arrest / physiopathology
  • Heart Arrest / therapy
  • Heart Rate / drug effects*
  • Humans
  • Male
  • Myocardial Perfusion Imaging / adverse effects*
  • Purines / adverse effects*
  • Pyrazoles / adverse effects*
  • Severity of Illness Index

Substances

  • Adenosine A2 Receptor Agonists
  • Purines
  • Pyrazoles
  • regadenoson